Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2.
- Angeja, Brad G.
- Rundle, A C
- Gurwitz, Jerry H.
- Gore, Joel M.
- Barron, Hal V.
DOIAbstract
In a retrospective cohort of patients treated in community hospitals, tissue plasminogen activator (t-PA) was associated with decreased odds of in-hospital death or nonfatal stroke. However, the relative benefit was less evident in older patients and women, and some older subgroups did not benefit from treatment
Add to ORKG